B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DNMT3B

MOLECULAR TARGET

DNA methyltransferase 3 beta

UniProt: Q9UBC3NCBI Gene: 17891 compounds

DNMT3B (DNA methyltransferase 3 beta) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DNMT3B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine1.614

About DNMT3B as a Drug Target

DNMT3B (DNA methyltransferase 3 beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented DNMT3B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DNMT3B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.